Usman Baber, M.D., presented study findings of patients at elevated risk for secondary myocardial infarction, during the 2020 Society for Cardiovascular Angiography and Interventions Scientific Sessions.
The University of Oklahoma College of Medicine has been awarded an $11 million federal grant to create the Oklahoma Center for Microbial Pathogenesis and Immunity, a hub for research into many types of infections and how the immune system recognizes and destroys them, or succumbs to them.
Receiving treatment on a clinical trial has not only controlled Deborrah Winters' cancer, but it has given her an opportunity to play a role in the advancement of cancer care for others as well.
For the fourth year in a row, Stephenson Cancer Center at OU Medicine is No. 1 in enrolling patients in clinical trials for the National Cancer Institute’s National Clinical Trials Network.
Stephenson Cancer Center at OU Medicine has been selected to join additional networks within the National Cancer Institute that will expand clinical trials in two areas – early-phase drugs to treat cancer and therapies to prevent cancer.
CAR-T, an innovative treatment that harnesses the body’s own immune cells to fight cancer, is now being offered at the Jimmy Everest Center for Cancer and Blood Disorders in Children for young people diagnosed with a type of leukemia.